Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic fibrosis during long-term low-dose methotrexate treatment
2008-001149-24Phase 4Active
- Sponsor
- CHU de Besançon
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methotrexate in psoriasis, Crohn's disease and rheumatoid arthritis (RA) (3 cohorts), sponsored by CHU de Besançon. Started May 2008; status: active.
02
Drugs
methotrexate
03
Conditions
psoriasisCrohn's diseaserheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-001149-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001149-24.